|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9601 USD | -2.13% |
|
-1.53% | -49.20% |
Vascular Biogenics Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 0.658 million compared to USD 0.768 million a year ago. Net loss was USD 32.3 million compared to USD 29.92 million a year ago.
Basic loss per share from continuing operations was USD 0.42 compared to USD 0.45 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -49.20% | 8.7M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
NOTABLE LABS, LTD. 
